The heart in the hypertensive elderly

Journal of Human Hypertension

Volumn 12, Issue 9, 1998, Pages 593-597

  Grodzicki, T ^a   Messerli, F H ^b,c  

^a Dept of Gerontology and Fam Med ^*  (Poland)

^b OCHSNER MEDICAL CENTER   (United States)

^c OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Drug therapy; Elderly; Essential hypertension; Left ventricular hypertrophy

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; VERAPAMIL;

AGING; ANTIHYPERTENSIVE THERAPY; CONFERENCE PAPER; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; HEART ARRHYTHMIA; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HUMAN; MYOFIBROSIS;

EID: 0031666427     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000671     Document Type: Conference Paper

References (51)

1. Lernfelt B, Wikstrand J, Svanborg A, Landahl S. Aging and left ventricular function in elderly healthy people. Am J Cardiol 1991; 68: 547-549.
2. Devereux RB et al. Left ventricular hypertrophy in hypertension. Prevalence and relationship to physiologic variables. Hypertension 1987; 9 (Suppl II): II53-II60.
3. Lakatta EG, Mitchell JH, Pomerance A, Rowe GG. Human aging: changes in structure and function. J Am Coll Cardiol 1987; 10 (Suppl A): 42-48.
4. Lie JT, Hammond PI. Pathology of the senescent heart: anatomic observations on 237 autopsy studies of patients 90 to 105 years old. Mayo Clin Proc 1988; 63: 552-564.
5. Hoogervorst HJ, Hoes AW, Grobbee DE. Electrocardiographic abnormalities in the elderly: findings in population-based studies. Cardiology in the Elderly 1994; 2: 21-27.
6. Furberg CD et al. Major electrocardiographic abnormalities in persons aged 65 years and older (the Cardiovascular Health Study). Cardiovascular Health Study Collaborative Research Group. Am J Cardiol 1992; 69: 1329-1335.
7. Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence and mortality in the Framingham Study. Ann Intern Med 1969; 71: 89-105.
8. Kocemba J, Gryglewska B, Klich A, Grodzicki T. Distribution of blood pressure and prevalence of arterial hypertension in the old population of Cracow. Materia Medica Polina 1991; 23: 33-35.
9. Levy D et al. Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987; 59: 956-960.
10. Olivetti G et al. Myocyte nuclear and possible cellular hyperplasia contribute to ventricular remodeling in the hypertrophic senescent heart in humans. J Am Coll Cardiol 1994; 24: 140-149.
11. Messerli FH et al. Clinical and hemodynamic determinants of left ventricular dimensions. Arch Intern Med 1984; 144: 477-481.
12. Van Hoof R. Left ventricular hypertrophy in elderly hypertensive patients: a report from the European Working Party on High Blood Pressure in the Elderly trial. Am J Med 1991; 90(3A): 55S-59S.
13. van den Hoogen JP et al. Prevalence of left ventricular hypertrophy as assessed by electrocardiogram in treated hypertensive persons in general practice. J Hum Hypertens 1993; 7: 473-477.
14. Aronow WS. Left ventricular hypertrophy. J Am Geriatr Soc 1992; 40: 71-80.
15. Casiglia E et al. Mortality in relation to Minnesota code items in elderly subjects. Sex-related differences in a cardiovascular study in the elderly. Jpn Heart J 1993; 34: 567-577.
16. Koren MJ et al, Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-352.
17. Aronow WS, Ahn C, Kronzon I, Koenigsberg M. Congestive heart failure, coronary events and atherothrombotic brain infarction in elderly blacks and whites with systemic hypertension and with and without echocardiographic and electrocardiographic evidence of left ventricular hypertrophy. Am J Cardiol 1991; 67: 295-299.
18. Kawamoto A et al. Factors associated with silent multiple lacunar lesions on magnetic resonance imaging in asymptomatic elderly hypertensive patients. Clin Exp Pharmacol Physiol 1991; 18: 605-610.
19. Strauer BE. Ventricular function and coronary hemodynamics in hpertensive heart disease. Am J Cardiol 1979; 44: 999-1006.
20. Behar S et al. Long-term prognosis after acute myocardial infarction in patients with left ventricular hypertrophy on the electrocardiogram. SPRINT Study Group. Am J Cardiol 1992; 69: 985-990.
21. Lavie CJ Jr, Nunez BD, Garavaglia GE, Messerli FH. Hypertensive concentric left ventricular hypertrophy: When is ventricular ectopic activity increased? South Med J 1988; 81: 696-700.
22. Messerli FH, Grodzicki T. Hypertension, left ventricular hypertrophy, ventricular arrhythmias and sudden death. Eur Heart J 1992; 13 (Suppl D): 66-69.
23. Kawecka-Jaszcz K et al. Ventricular arrhythmias and echocardiographic parameters of the left ventricular morphology in elderly patients with arterial hypertension. Eur J Clin Pharmacol 1990; 39 (Suppl): S47-48.
24. Palatini P et al. Impaired left ventricular filling in hypertensive left ventricular hypertrophy as a marker of the presence of an arrhythmogenic substrate. Br Heart J 1995; 73: 258-262.
25. Takasaki M, Matsumoto M, You-Bin Deng. Echocardiographic assessment of left ventricular diastolic function in elderly hypertensive patients. Cardiology in the Elderly 1996; 4: 185-190.
26. Gardin JM et al. Doppler echocardiographic assessment of left ventricular systolic and diastolic function in mild hypertension. Hypertension 1987; 9 (2 pt 2): II-90-II-96.
27. Dahan M, Paillole C, Ferreira B, Gourgon R. Doppler echocardiographic study of the consequences of aging and hypertension on the left ventricle and aorta. Eur Heart J 1990; 11 (Suppl G): 39-45.
28. Grodzicki T, Michalewicz L, Messerli FH. Aging and essential hypertension: effect of left ventricular hypertrophy on cardiac function. Am J Hypertens 1998; 11: 425-429.
29. Topol EJ, Traill TA, Fortuin NJ. Hypertensive hypertrophic cardiomyopathy of the elderly. N Engl J Med 1985; 312: 277-283.
30. Gardin JM et al. Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly. The Cardiovascular Health Study. Circulation 1995; 91: 1739-1748.
31. Grossman E, Oren S, Messerli FH. Left ventricular mass and cardiac function in patients with essential hypertension. J Hum Hypertens 1994; 8: 417-421.
32. Iivanainen AM et al, Echocardiographic, Doppler and clinical findings predict survival in the elderly. Cardiology in the Elderly 1996; 4: 213-218.
33. Devereux RB et al. Regression of left ventricular hypertrophy as a surrogate end-point for morbid events in hypertension treatment trials. J Hypertens Suppl 1996; 14: S95-S102.
34. Muiesan ML et al. Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment. J Hypertens 1995; 13: 1091-1095.
35. Levy D et al. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 1994; 90: 1786-1793.
36. Koren MJ, Ulin RJ, Laragh JH, Devereux RB. Reduction in left ventricular mass during treatment of essential hypertension is associated with improved prognosis [abstract]. Am J Hypertens 1994; 5 (Suppl): 182s-189s.
37. Grodzicki T, Messerli FH, Soria F, Aristizabal D. Antihypertensive therapy and regression of left ventricular mass, J Hypertens 1993; 11 (Suppl 5): S364-S365.
38. Panizo-Santos A et al. Angiotensin converting enzyme inhibition prevents polyploidization of cardiomyocytes in spontaneously hypertensive rats with left ventricular hypertrophy. J Pathol 1995; 177: 431-437.
39. Brilla CG, Maisch B, Zhou G, Weber KT. Hormonal regulation of cardiac fibroblast function. Eur Heart J 1995; 16 (Suppl C): 45-50.
40. Diez J et al. Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations. Circulation 1995; 91: 1450-1456.
41. Schmieder RE, Martus P, Kingbeil A: Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. JAMA 1996; 275: 1507-1513.
42. Gottdiener JS et al. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Circulation. 1997; 95: 2007-2014.
43. Grodzicki T, Messerli FH. The elderly hypertensive. In: Kaplan N, Ram CVS (eds). Individualized Therapy of Hypertension. Marcel Dekker, Inc: New York, 1995, pp 47-63.
44. Dahlof B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens 1992; 5: 95-110.
45. Schmieder RE, Messerli FH, Garavaglia GE, Nunez BD. Cardiovascular effects of verapamil in patients with essential hypertension. Circulation 1987; 75: 1030-1036.
46. Schulman SP et al. The effect of antihypertensive therapy on left ventricular mass in elderly patients. N Engl J Med 1990; 322: 1350-1356,
47. Arrighi JA et al. Improvement of the age-related impairment in left ventricular diastolic filling with verapamil in the normal human heart. Circulation 1994; 90: 213-219.
48. Goodfriend TL, Elliott ME, Catt KJ. Angiotensin receptors and their antagonists. N Engl J Med 1996; 334: 1649-1654.
49. Cheung B. Increased left-ventricular mass after losartan treatment. Lancet 1997; 349: 1743-1744.
50. Himmelman A, Svensson A, Bergbnrant A, Hansson L. Long-term effects of losartan on blood pressure and left ventricular structure in essential hypertension. J Hum Hypertens 1996; 10: 729-734.
51. Wikstrand J, Kendall M. The role of beta receptor blockade in preventing sudden death. Eur Heart J 1992; 13 (Suppl D): 111-120.